Hilbe W - Search Results

1

Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation: a preclinical model for minimal residual disease.

Kühr T, Bechter O, Geley S, Eisterer W, Lukas P, Url M, Dietrich H, Hilbe W, Kofler R, Thaler J. Kühr T, et al. Among authors: hilbe w. Exp Hematol. 1999 Feb;27(2):266-71. doi: 10.1016/s0301-472x(98)00006-x. Exp Hematol. 1999. PMID: 10029166 Free article.

2

Transplantation of IL-2-transduced murine bone marrow is associated with dose-dependent toxicity.

Kühr T, Bechter O, Dirnhofer S, Geley S, Gächter A, Pall G, Url M, Dietrich H, Oberaigner P, Klima G, Eisterer W, Hilbe W, Lukas P, Thaler J. Kühr T, et al. Among authors: hilbe w. Exp Hematol. 2000 Aug;28(8):895-906. doi: 10.1016/s0301-472x(00)00487-2. Exp Hematol. 2000. PMID: 10989190 Free article.

3

Identification of a favorable subgroup of patients with generalized immunocytomas by follicular dendritic cells.

Eisterer W, Hilbe W, Fend F, Ludescher C, Falk M, Thaler J. Eisterer W, et al. Among authors: hilbe w. Leukemia. 1995 Feb;9(2):254-9. Leukemia. 1995. PMID: 7869760

4

Low frequency of activity of P-glycoprotein (P-170) in acute lymphoblastic leukemia compared to acute myeloid leukemia.

Ludescher C, Eisterer W, Hilbe W, Gotwald M, Hofmann J, Zabernigg A, Cianfriglia M, Thaler J. Ludescher C, et al. Among authors: hilbe w. Leukemia. 1995 Feb;9(2):350-6. Leukemia. 1995. PMID: 7869774

5

[Functional detection of P-glycoprotein expressing cells with flow cytometry].

Ludescher C, Hilbe W, Eisterer W, Preuss E, Hofmann J, Thaler J. Ludescher C, et al. Among authors: hilbe w. Wien Klin Wochenschr. 1994;106(8):242-6. Wien Klin Wochenschr. 1994. PMID: 7912868 German.

6

Treatment of relapsed and refractory acute myelogenous leukaemia with aclacinomycin A (ACA) and etoposide (VP-16).

Hilbe W, Thaler J, Eisterer W, Ludescher C, Niederwieser D. Hilbe W, et al. Leuk Res. 1994 Sep;18(9):655-8. doi: 10.1016/0145-2126(94)90063-9. Leuk Res. 1994. PMID: 7934139 Clinical Trial.

7

Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.

Ludescher C, Hilbe W, Eisterer W, Preuss E, Huber C, Gotwald M, Hofmann J, Thaler J. Ludescher C, et al. Among authors: hilbe w. J Natl Cancer Inst. 1993 Nov 3;85(21):1751-8. doi: 10.1093/jnci/85.21.1751. J Natl Cancer Inst. 1993. PMID: 8105101

8

Decreased potency of MDR-modulators under serum conditions determined by a functional assay.

Ludescher C, Eisterer W, Hilbe W, Hofmann J, Thaler J. Ludescher C, et al. Among authors: hilbe w. Br J Haematol. 1995 Nov;91(3):652-7. doi: 10.1111/j.1365-2141.1995.tb05362.x. Br J Haematol. 1995. PMID: 8555069

9

Comparative analysis of two consecutive phase II studies with IFN-alpha and IFN-alpha + ara-C in untreated chronic-phase CML patients. Austrian CML Study Group.

Thaler J, Hilbe W. Thaler J, et al. Among authors: hilbe w. Bone Marrow Transplant. 1996 May;17 Suppl 3:S25-8. Bone Marrow Transplant. 1996. PMID: 8769696 Clinical Trial.

10

Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.

Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J. Konwalinka G, et al. Among authors: hilbe w. Blood Cells Mol Dis. 1995;21(2):142-51. doi: 10.1006/bcmd.1995.0016. Blood Cells Mol Dis. 1995. PMID: 8846043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters